We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$54.7B
AUM Growth
+$1.45B
Cap. Flow
+$1.02B
Cap. Flow %
1.86%
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$65.3M
2
GPN icon
Global Payments
GPN
+$40.3M
3
MSFT icon
Microsoft
MSFT
+$37.9M
4
LHX icon
L3Harris
LHX
+$32.8M
5
AMZN icon
Amazon
AMZN
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 18.64%
2 Financials 15.56%
3 Healthcare 12.85%
4 Consumer Discretionary 10.31%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEYS icon
2676
Weyco Group
WEYS
$419M
$243K ﹤0.01%
10,751
+772
+8% +$19.2K
INSG icon
2677
Inseego
INSG
$121M
$242K ﹤0.01%
5,049
+810
+19% +$37.7K
GRTS
2678
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$242K ﹤0.01%
28,053
+2,774
+11% +$28K
TLPH icon
2679
Talphera
TLPH
$70.1M
$241K ﹤0.01%
5,484
+459
+9% +$22.6K
ALCO icon
2680
Alico
ALCO
$283M
$240K ﹤0.01%
+7,047
New +$223K
SD icon
2681
SandRidge Energy
SD
$488M
$240K ﹤0.01%
51,163
+5,401
+12% +$30.9K
JAX
2682
DELISTED
J. Alexander's Holdings, Inc.
JAX
$240K ﹤0.01%
20,484
+1,878
+10% +$21.2K
FVCB icon
2683
FVCBankcorp
FVCB
$341M
$239K ﹤0.01%
17,041
+2,007
+13% +$28.6K
LVGO
2684
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$238K ﹤0.01%
+13,639
New +$412K
CMLS
2685
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$237K ﹤0.01%
16,276
+2,256
+16% +$33.9K
MDLA
2686
DELISTED
Medallia, Inc.
MDLA
$236K ﹤0.01%
+8,621
New +$306K
LJPC
2687
DELISTED
La Jolla Pharmaceutical Company
LJPC
$236K ﹤0.01%
26,769
-185
-0.7% -$1.75K
TH icon
2688
Target Hospitality
TH
$1.57B
$235K ﹤0.01%
34,476
+4,069
+13% +$30.8K
REV
2689
DELISTED
Revlon, Inc.
REV
$234K ﹤0.01%
+9,966
New +$188K
FNHC
2690
DELISTED
FedNat Holding Company Common Stock
FNHC
$233K ﹤0.01%
16,675
+751
+5% +$9.8K
HCAT icon
2691
Health Catalyst
HCAT
$176M
$232K ﹤0.01%
+7,346
New +$289K
PCYO icon
2692
Pure Cycle
PCYO
$255M
$232K ﹤0.01%
22,605
-175
-0.8% -$1.87K
PTN
2693
Palatin Technologies
PTN
$14.2M
$232K ﹤0.01%
205
-1
-0.5% -$1.17K
TPCO
2694
DELISTED
Tribune Publishing Company Common Stock
TPCO
$232K ﹤0.01%
27,012
+2,238
+9% +$17.9K
EOLS icon
2695
Evolus
EOLS
$406M
$231K ﹤0.01%
14,797
+1,953
+15% +$32K
MPB icon
2696
Mid Penn Bancorp
MPB
$969M
$231K ﹤0.01%
9,016
+823
+10% +$20.6K
ASPS icon
2697
Altisource Portfolio Solutions
ASPS
$63.4M
$230K ﹤0.01%
1,424
+91
+7% +$14.9K
CHMG icon
2698
Chemung Financial Corp
CHMG
$398M
$229K ﹤0.01%
5,453
+449
+9% +$19.6K
OVBC icon
2699
Ohio Valley Banc Corp
OVBC
$202M
$229K ﹤0.01%
6,277
+600
+11% +$21K
FLXS icon
2700
Flexsteel Industries
FLXS
$315M
$228K ﹤0.01%
15,369
+2,222
+17% +$36.2K

Similar funds

RhumbLine Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
  • RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
  • RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
  • RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
  • RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.

Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.